The U.S. Department of Defense's Defense Health Agency has awarded a $1,179,730 Project Grant to The Research Foundation for the State University of New York (RF-SUNY) at the University at Albany. The grant, under the Military Medical Research and Development program (CFDA 12.420), will fund research to identify new biological and therapeutic targets for myotonic dystrophy type 1, a genetic disorder affecting muscle function. The four-year grant, which began on April 1, 2024, will support basic, translational, and clinical research aimed at developing innovative treatments and advancing the understanding of this condition, which is a priority for military medicine. As a leading non-profit research organization, RF-SUNY has a demonstrated track record of conducting impactful biomedical research through federal contracts and grants, including work for the Department of Defense, NASA, and NOAA.
Generated 12/10/24, 11:09 AM